FDA Approves Widaplik: The First Triple-Combination Pill for Hypertension Treatment
A groundbreaking step in cardiovascular care as the U.S. FDA greenlights Widaplik, a once-daily pill combining telmisartan, amlodipine, and indapamide. In a major leap forward for hypertension management, the U.S.